| Article
Newswise — As research continues to show progress towards minimizing the effects of headache disorders on patients’ lives, Practical Neurology® gathered insights from experts in the field at The American Headache Society (AHS) 61stAnnual Scientific Meeting this year, where new data looking at a...
| Article
Newswise — Clarksville resident Hope Dyer remembers the day she looked out a window, saw it was raining and immediately began crying. She realized it was the first time in more than two decades that a drop in barometric pressure before a storm hadn’t triggered a debilitating migraine.
In November...
| Article
Newswise — An increasing number of Americans are using opioids to treat their migraine headaches, despite the fact that opioids are not the recommended first-line therapy for migraine in most cases. That’s according to the ObserVational Survey of the Epidemiology, tReatment and Care Of MigrainE...
| Article
American Headache Society: Chronic Migraine Education Program
Developed by the American Headache Society, the Chronic Migraine Education Program (CMEP) includes new advances and addresses acute and preventive treatment options. In addition...
Listen to part 1 of the podcast
Part 1...
| Podcast
Developed by the American Headache Society®, the Chronic Migraine Education Program (CMEP) includes new advances and addresses acute and preventive treatment options. In addition, the CMEP highlights epidemiologic data on the scope and distribution of migraine with an emphasis on diagnosing chronic...
| Podcast
Developed by the American Headache Society®, the Chronic Migraine Education Program (CMEP) includes new advances and addresses acute and preventive treatment options. In addition, the CMEP highlights epidemiologic data on the scope and distribution of migraine with an emphasis on diagnosing chronic...
| Article
Newswise — Migraine sufferers who used a smartphone-based relaxation technique at least twice a week experienced on average four fewer headache days per month, a new study shows.
Developed in part by researchers at NYU School of Medicine, the app, called RELAXaHEAD, guides patients through...
| Article
Newswise—June is migraine and headache awareness month. Migraine affects more than 38 million Americans and is the third most common condition worldwide. Despite such a vast number of sufferers, however, significant development of migraine treatment options continue to lag.
According to Regina...
| Video
Dr. Jay discusses an emerging class of medications that represents a paradigm shift in the treatment of migraine: CGRP receptor antagonists. But there’s more to managing migraine than just the medication…